3 Recruiting Epithelial Ovarian Cancer Phase 3 Clinical Trials
Active phase 3 studies for epithelial ovarian cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Epithelial Ovarian Cancer studiesPhase 3 Studies for Epithelial Ovarian Cancer
🔵 Active, Not Recruiting Phase3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
📍 Arizona Oncology Associates, PC - HAL — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
📍 Advent Health — Orlando, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase3
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔